RxDoctor Payments Data

Giovanni Catalano, DO

Family Medicine · Quakertown, PANPI 1306819800

Payments from drug & device makers

$1,096in general payments, 2019–2025

Across 41 payments — averaging $26.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$220
  • AbbVie$220
  • Smith+Nephew$116
  • Organogenesis Inc.$116
  • Integra Lifesciences Corporation$112
  • Acella Pharmaceuticals, LLC$90
  • plus $222 from 6 others

What the payments were for

  • Food & beverage$1,096100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,096 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$112,308
Medicare patients
337
Services billed
3,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GamastanImmune Globul G (Igg)/Glycine13$7,937
Armour ThyroidThyroid,pork67$5,491
Np ThyroidThyroid,pork12$1,508
Liothyronine Sodium17$828
Levothyroxine Sodium51$612
Lisinopril65$473
Amlodipine Besylate46$303
Hydrocortisone13$254
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine18$220
Lorazepam27$194
Metformin Hcl12$182
Metformin Hcl ErMetformin Hcl19$166
Cyclobenzaprine Hcl11$150
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav16$148
Metoprolol Tartrate15$129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieArmour Thyroid$220$5,49167 claims
Acella Pharmaceuticals, LLCNp Thyroid$90$1,50812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Quakertown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →